Biotech Stocks: Why Illumina is THE Company to Watch in Genomic Sequencing

The first company is a leader in genomic sequencing, providing the machines used for more than 90% of the world’s DNA tests and empowering the personalized medicine movement. The second is an undervalued global drugmaker, whose big bets on diagnostics are paying off for the development of personalized drugs. And the third is a pure-play on liquid biopsies, whose much-hyped recent IPO could be worth the buzz for risk-tolerant investors.

In the following video, Industry Focus: Healthcare host Shannon Jones and Motley Fool contributor Simon Erickson describe the businesses, opportunities, and investor base of their top three stock ideas. Simon also shares his favorite company of the three.
------------------------------------------------------------------------
Subscribe to The Motley Fool's YouTube Channel:
http://www.youtube.com/TheMotleyFool
Or, follow our Google+ page:
https://plus.google.com/+MotleyFool/posts

Inside The Motley Fool: Check out our Culture Blog!
http://culture.fool.com
Join our Facebook community:
https://www.facebook.com/themotleyfool
Follow The Motley Fool on Twitter:
https://twitter.com/themotleyfool

Видео Biotech Stocks: Why Illumina is THE Company to Watch in Genomic Sequencing канала The Motley Fool